NDC 73575-010

Pliaglis

Lidocaine And Tetracaine

Pliaglis is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Oba Pharmaceuticals, Inc.. The primary component is Lidocaine; Tetracaine.

Product ID73575-010_92f4411a-9390-41b3-a643-6626d8c6cb48
NDC73575-010
Product TypeHuman Prescription Drug
Proprietary NamePliaglis
Generic NameLidocaine And Tetracaine
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2020-01-24
Marketing CategoryNDA / NDA
Application NumberNDA021717
Labeler NameOba Pharmaceuticals, Inc.
Substance NameLIDOCAINE; TETRACAINE
Active Ingredient Strength70 mg/g; mg/g
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Esters [CS],Local Anesthesia [PE],Ester Local Anesthetic [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 73575-010-02

2 TUBE in 1 CARTON (73575-010-02) > 30 g in 1 TUBE
Marketing Start Date2020-01-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pliaglis" or generic name "Lidocaine And Tetracaine"

NDCBrand NameGeneric Name
0299-6100PLIAGLISlidocaine and tetracaine
51672-5305PLIAGLISLidocaine and Tetracaine
73575-009Pliaglislidocaine and tetracaine
73575-010Pliaglislidocaine and tetracaine
69420-3077LIDOCAINE AND TETRACAINELIDOCAINE AND TETRACAINE
71800-631Lidocaine and TetracaineLidocaine and Tetracaine
10885-002Syneralidocaine and tetracaine

Trademark Results [Pliaglis]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PLIAGLIS
PLIAGLIS
78950628 3413447 Live/Registered
CRESCITA THERAPEUTICS INC.
2006-08-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.